A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Abstract Background We aimed to evaluate the efficacy and safety of nab-paclitaxel in patients with refractory advanced non-small cell lung cancer who failed previous chemotherapy. Methods Patients were required to have an Eastern Cooperative Oncology Group performance status of 0–2 and adequate org...

Full description

Bibliographic Details
Main Authors: Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, Yoshihito Tanaka, Masamichi Itoga, Kunihiko Nakamura, Akihito Hayashi, Mika Kumagai, Hideo Yasugahira, Megumi Mikuniya, Koichi Okudera, Shingo Takanashi, Sadatomo Tasaka
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Cancer
Subjects:
Lung cancer
Nab-paclitaxel
Refractory
Online Access:http://link.springer.com/article/10.1186/s12885-017-3684-8

Internet

http://link.springer.com/article/10.1186/s12885-017-3684-8

Similar Items